These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23279805)

  • 1. Performance standards and alternative assays: practical insights from skin sensitization.
    Kolle SN; Basketter DA; Casati S; Stokes WS; Strickland J; van Ravenzwaay B; Vohr HW; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):278-85. PubMed ID: 23279805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency.
    Nukada Y; Ashikaga T; Miyazawa M; Hirota M; Sakaguchi H; Sasa H; Nishiyama N
    Toxicol In Vitro; 2012 Oct; 26(7):1150-60. PubMed ID: 22796097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin sensitization, false positives and false negatives: experience with guinea pig assays.
    Basketter DA; Kimber I
    J Appl Toxicol; 2010 Jul; 30(5):381-6. PubMed ID: 20583317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with local lymph node assay performance standards using standard radioactivity and nonradioactive cell count measurements.
    Basketter D; Kolle SN; Schrage A; Honarvar N; Gamer AO; van Ravenzwaay B; Landsiedel R
    J Appl Toxicol; 2012 Aug; 32(8):590-6. PubMed ID: 21618258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
    Aptula AO; Patlewicz G; Roberts DW; Schultz TW
    Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4.
    Ha S; Ahn IY; Kim DE; Lee JK; Sohn S; Jung MS; Heo Y; Omori T; Bae S; Lim KM
    Regul Toxicol Pharmacol; 2017 Apr; 85():124-131. PubMed ID: 28193562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.
    Haneke KE; Tice RR; Carson BL; Margolin BH; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):274-86. PubMed ID: 11754531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods.
    Gerberick GF; Ryan CA; Kern PS; Schlatter H; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Dermatitis; 2005 Dec; 16(4):157-202. PubMed ID: 16536334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test--human cell line activation test (h-CLAT).
    Sakaguchi H; Ashikaga T; Miyazawa M; Kosaka N; Ito Y; Yoneyama K; Sono S; Itagaki H; Toyoda H; Suzuki H
    Cell Biol Toxicol; 2009 Apr; 25(2):109-26. PubMed ID: 18204907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of an Integrated Testing Strategy consisting of in silico, in chemico and in vitro assays for evaluating the skin sensitization potencies of isocyanates.
    Ohtake T; Maeda Y; Hayashi T; Yamanaka H; Nakai M; Takeyoshi M
    Toxicology; 2018 Jan; 393():9-14. PubMed ID: 29100879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization.
    Piroird C; Ovigne JM; Rousset F; Martinozzi-Teissier S; Gomes C; Cotovio J; Alépée N
    Toxicol In Vitro; 2015 Aug; 29(5):901-16. PubMed ID: 25820135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local lymph node assay: validation assessment for regulatory purposes.
    Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
    Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process.
    Sailstad DM; Hattan D; Hill RN; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):249-57. PubMed ID: 11754529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accounting for data variability, a key factor in in vivo/in vitro relationships: application to the skin sensitization potency (in vivo LLNA versus in vitro DPRA) example.
    Dimitrov S; Detroyer A; Piroird C; Gomes C; Eilstein J; Pauloin T; Kuseva C; Ivanova H; Popova I; Karakolev Y; Ringeissen S; Mekenyan O
    J Appl Toxicol; 2016 Dec; 36(12):1568-1578. PubMed ID: 27080242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appraisal of within- and between-laboratory reproducibility of non-radioisotopic local lymph node assay using flow cytometry, LLNA:BrdU-FCM: comparison of OECD TG429 performance standard and statistical evaluation.
    Yang H; Na J; Jang WH; Jung MS; Jeon JY; Heo Y; Yeo KW; Jo JH; Lim KM; Bae S
    Toxicol Lett; 2015 May; 234(3):172-9. PubMed ID: 25732604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further experience with the local lymph node assay using standard radioactive and nonradioactive cell count measurements.
    Kolle SN; Basketter D; Schrage A; Gamer AO; van Ravenzwaay B; Landsiedel R
    J Appl Toxicol; 2012 Aug; 32(8):597-607. PubMed ID: 22627909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.